Comments WLFI.com is migrating to a more stable commenting system called DISQUS. This system is used by CNN, TIME, FOX News, numerous blogging sites and has over 75 Million registered users. Unfortunately we can't migrate our current user accounts to this new system.
To sign up for a DISQUS account, click the DISQUS button just below and to the right and then click Login.
DISQUS lets you login with several different options, including Facebook, Google, Twitter, Yahoo or OpenID. We expect it to allow more conversation and better moderation. If you have any questions, please feel free to comment below.
Cubist Pharma names Michael Tomsicek as new CFO
Updated: Monday, 04 Mar 2013, 12:22 PM EST
Published : Monday, 04 Mar 2013, 12:22 PM EST
LEXINGTON, Mass. (AP) — Cubist Pharmaceuticals Inc. said Monday that Michael Tomsicek will replace David McGirr as chief financial officer.
Tomsicek has been the company's deputy CFO since July. McGirr is now the senior adviser to CEO Mike Bonney, and he will retire from the company in 2014.
McGirr has been Cubist's CFO since November 2002. Tomsicek joined Cubist in 2010 as head of corporate finance.
Cubist shares rose 69 cents, or 1.6 percent, to $44.16 in midday trading. They are trading near the upper end of their 52-week range of $36.73 to $49.86.
Email This
Print This
View Story on a Single PageAdvertisement
Advertisement